The Colorado Department of Public Health and Environment (CDPHE) administers the metabolic (dried blood spot testing) portion of the Colorado Newborn Screening (NBS) Program.
A trend in reporting errors for NBS results has been noticed due to manual typing of NBS results into facility electronic records. Be aware that the contents of CDPHE's NBS reports are dynamic, and reports should be reviewed completely and carefully before being entered manually into an electronic record system.
CDPHE provides contracted follow-up consultation services for the metabolic portion of the CO NBS Program with the following medical experts:
Hemoglobinopathies-CU Medicine/Colorado Sickle Cell Center
Severe Combined Immunodeficiency (SCID)-CU Medicine/Children's Hospital Colorado
Congenital Hypothyroidism-Rocky Mountain Pediatric Endocrinology
Cystic Fibrosis (CF)-CU Medicine
Congenital Adrenal Hyperplasia (CAH)-CU Medicine
Inherited Metabolic Diseases-CU Medicine
These are the only clinical consultants contracted by CDPHE to serve in follow-up roles for blood spot testing. A physician from one of these groups will contact a child's primary care provider or a physician from the submitting institution when screening results suggest risk of an underlying medical condition.
Contact the Colorado Newborn Screening Program Manager, Dr. Darren Michael, at darren.michael@state.co.us or 303-692-3673 with any questions about these issues related to reporting of NBS results or contracted services.
This blog publishes information typically sent to users of the Colorado Health Facilities Interactive (COHFI) system for health care entities regulated by the Colorado Department of Public Health and Environment. Please note that COHFI is the official medium for business communication between the Department and licensed and/or Medicare/Medicaid certified health care entities. Health care entities should continue to monitor their email accounts routinely.
